Santhera Pharmaceuticals (OTCMKTS:SPHDF – Get Rating) is one of 412 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Santhera Pharmaceuticals to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation. Institutional and Insider Ownership 8.2% of Santhera […]
Santhera Pharmaceuticals (OTCMKTS:SPHDF – Get Rating) is one of 334 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Santhera Pharmaceuticals to related companies based on the strength of its profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Institutional & Insider Ownership 8.2% of Santhera […]
Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 348,500 shares, an increase of 20.5% from the May 15th total of 289,200 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio […]
Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 348,500 shares, a growth of 20.5% from the May 15th total of 289,200 shares. Based on an average daily trading volume, of 0 […]
Santhera Pharmaceuticals (OTCMKTS:SPHDF – Get Rating) is one of 346 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Santhera Pharmaceuticals to similar companies based on the strength of its analyst recommendations, earnings, profitability, dividends, institutional ownership, valuation and risk. Analyst Recommendations This is a summary of […]